Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Listen to the patient, don't dismiss them, but be honest
Inflammatory Bowel Disease Models Research using animal models of IBD (both Crohn's-like and ulcerative colitis-like conditions) has shown BPC-157 [12]: Reduces intestinal inflammation Accelerates mucosal healing Preserves intestinal barrier function Decreases inflammatory cytokine production Prevents fistula formation in some models Intestinal Anastomosis Healing Surgical studies demonstrated that BPC-157 significantly improves the healing of intestinal anastomoses (surgical connections), potentially reducing complications like leakage and stricture formation [13]
[28] Additional effects: anti-tumor activity (Folkmans concept), neurotransmitter modulation, and broad cytoprotective/organoprotective profile
In total, nine treated patients had significantly reduced discomfort and improved tear volume production, even 28 days following treatment
